Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 2 (RPL17P2)

Target: RPL17P2
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L17 pseudogene 2 (RPL17P2) is a processed pseudogene of the ribosomal protein L17 (RPL17) gene found in the human genome[4][2]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they arise from genomic duplication or retrotransposition events and typically do not encode functional proteins[2][6]. RPL17P2 does not produce a functional protein and is not implicated as a disease gene or therapeutic target. It has no established biological function, drug interactions, or known relevance as a biomarker or safety concern.

Other names: RPL17_13_1376RPL17P2

Biological functions

Other (No known function; pseudogenes are typically non-functional genomic segments)

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 2 (RPL17P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 2 (RPL17P2).

Explore the full profile